Neurotransmitter receptors and postsynaptic signal transmission (Homo sapiens)

From WikiPathways

Revision as of 19:13, 31 October 2018 by ReactomeTeam (Talk | contribs)
Jump to: navigation, search
468125, 54, 8215, 7918, 72343763220, 596862, 7824, 63, 67381, 7, 11, 35, 40...36, 48, 57, 58, 611614642856419335621, 23, 31, 34, 55...1213647139, 50, 524262, 7864564910, 73532, 37, 41, 65131315, 792926, 3017128, 51, 60227577695cytosolnucleoplasmendocytic vesicle membraneADCY9 DLG1GRIN2D ATPADCY7 ADPGNGT1 ADCY6 GNAL cAMPGly ADCY2 AKAP9 p-T287-CAMK2B GNG11 Ca impermeable AMPAreceptorsGABRR pentamer:GABAGNAI1 Calmodulin:CaMK IV5HT Ca permeable AMPAreceptor ligandcomplexp-T286-CAMK2A CHRNE AKAP5CHRNA5 ADCY6 p-S232,S372,S389,T581-RPS6KA6 Edited GRIK2 (GluR6) NMDA receptor ligandcomplexCHRNA9 CALM1GRIA3 p-T287-CAMK2G Ca2+GLRA2 AKAP5GABRA6 MAPK1HTR3B CACNG2 ADCY8 ADCY6 p-T286-CAMK2A p-T287-CAMK2B GNAI3 CHRNA4 GABBR1 NPTNGRIP2 0-acteylcholinebound to calciumpermeable nictonicacteylcholinereceptor complexCALM1 CHRNA6 ADCY9 NMDA receptor-MgcomplexGABRA5 ADCY6 KCNJ5 GLRA:GLRB:GlyCa permeable AMPAreceptorsHRAS:GTPACTN2 AcCho HRAS PDPK1GRIA4 PRKACG GRIN2D CALM1:4xCa2+CACNG3 CACNG4 GRIA1 p-T287-CAMK2G CALM1 GNG2 NEFL GNG5 G-protein alpha(i):GDPMg2+ Ca impermeable AMPAreceptor ligandcomplexADPKainatereceptor-glutamatecomplexGRIK3 GABRA3 GRIA3 GRIN1 KCNJ3 AcCho GRIN2A CHRNA3 CHRNA4 GNAI2 GRIN2C Ca2+ GABRA1 p-T287-CAMK2G L-Glup-T287-CAMK2G PiL-Glu GABBR2 p-T286-CAMK2A p-S338-BRAF ADCY5 Edited GRIK2 (GluR6) DLG3 MDM2 ATPGRIP2 GRIA3 PSD-95 GRIA4 GRIK4 CHRNB2 TSPAN7:PICK1ADCY5 CHRNA7 GRIA3 NEFL L-GluMYO6AP2B1-1 NCALD DLG1 ADCY1 ADPKCNJ16 GNG7 CHRNB2 CHRNB2 GNAI1 p-S372,S389,T581-RPS6KA6 GNG5 CHRNA4 AP2A1 GABA B receptorG-proteinbeta-gamma and Kir3channel complexNEFL PRKACB K+GNG2 p-T286-CAMK2A ADCY2 GRIK5 CHRNA2 DLG1 GNB4 PRKCG RPS6KA1 Ca2+p-S880-GRIA2 CHRNB4 ADCY4 DLG1ADCY2 GRIK 3 homomerGNAI2 GRIN2C RasGTP-B raf compexGNG2 CHRNA5 GABRQ Gly GABBR1 Na+Adenylate cyclase(Mg2+ cofactor)GNAT3 AP2A2-3 p-S360,S377,T570-RPS6KA2 Highly calciumpermeable nicotinicacetylcholinereceptors(Gialpha1:GTP:Adenylate cyclase):(G alpha-olf:GDP)ADCY7 L-Glu CHRNA2 GABA p-S221,S363,S380,T573-RPS6KA1 GABRQ GABRheteropentamers:GABA:NPTNGNB1 GNAT3 CHRNA3 L-GluCaMKIIKCNJ15 RRAS CHRNA4 CaMKIIK+GNB1 L-Glu Ca impermeable AMPAreceptors (withphospho GluR2 S880)GNAI3 GRIA1 Ca2+GRIP1 KCNJ6 GTP MYO6L-Glu GNAT3 CHRNB2 PLCB3 p-T287-CAMK2B CHRNA4 ADCY8 PSD-95 CREB1CAMK4 GABRB2 Edited KainateReceptor-glutamatecomplexCl- GABRB1 Kainate ReceptorsARHGEF9 PRKACA GTP GABA ADCY5 PiPICK1GNG4 O-Acetylcholinebound toAcetylcholinereceptorPhospho(S363,S380,T573)-ribosomal S6 kinaseAKAP9 Ca impermeable AMPAreceptorsGNAT3 GlyAP2S1-1 p-T286-CAMK2A (Gialpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)Ca2+ G alpha (i): GTPGABRR2 GNAI2 CALM1 GRIA2 GRIN2B HTR3A GRIA3 TARP-PSD95-Mdm2Na+MDM2 Cl- GABAB receptor:GABAADCY3 NCALD GNAI2 GNAI3 p-S12,S13-CAMK4 GRIK1 KCNJ12 p-T287-CAMK2D Ca2+ATPp-S369,S386,T573-RPS6KA3 p-S338-RAF1CHRNB3 GABRG3 GLRA3 GABRA6 GRIN2A Ca2+CHRNA5 ADCY2 GRIA4 GRIA4 GNG11 ADPCAMK4p-T287-CAMK2D GNB3 ADCY8 GDP p-T287-CAMK2D GRIK3 RASGRF2 Phospho(S221,S363,S380,T573)- ribosomal S6 kinaseADPADCY1 ACTN2 GRIK5 L-GluGNAT3 CHRNB4 ADPNSFGRIN2C ACTN2 p-T287-CAMK2D Ca2+ PiGNGT1 CHRNB3 GDP ADCY1 HRAS:GDPPICK1p-T287-CAMK2D EPB41L1GABRA3 GABRR1 ACTN2 Ca impermeable AMPAreceptorsATPCALM1 Mg2+ RasGRF:Ca/calmodulinGNB5 GNG3 GABBR2 GRIP2 GRIA3 p-T287-CAMK2B GNAI3 GABRG3 p-T287-CAMK2B p-S363,S380,T573-RPS6KA1 RASGRF1 ADCY2 CHRNB2 CACNG8 p-T287-CAMK2G NEFL GABAGRIK3 GNAI3 GRIP1 GABRA1 p-T287-CAMK2B GNG12 p-S369,S386,T573-RPS6KA3 p-T287-CAMK2D p-T287-CAMK2D Cl- ATPGRIN2D p-T287-CAMK2D CHRND AKAP9 TARP-PSD95-Mdm2GRIK4 GDP Na+Phospho(S363,S380,T573)- ribosomal S6 kinasePRKACB-like proteinsGNB3 p-T287-CAMK2G GABRA2 GRIP1 p-T286-CAMK2A CACNG3 p-S227,S369,S386,T573-RPS6KA3 Highly sodiumpermeable nicotinicacetylcholinereceptorsGNAI1 Mg2+ p-T287-CAMK2G Mg2+ ARHGEF9 ATPGNG3 Ca2+ CALM1 p-T287-CAMK2B CHRNB2 GRIK3 ADCY8 p-T287-CAMK2B CHRNA6 Mg2+ L-GluGRIA2 GNAL NEFL p-T287-CAMK2D L-Glu Na+GNB4 HTR3 pentamer:5HTADCY1 ADPGRIN1 p-S372,S389,T581-RPS6KA6 GNG7 G-proteinbeta-gamma:PLC beta1/2/3CHRND p-T286-CAMK2A PSD-95 GNG7 AKAP9 GABA Edited GRIK 1 (GluR5) KCNJ2 GTP PICK1HRAS GRIP1/GRIP2Edited GRIK 1 (GluR5) PICK1 KCNJ10 CALM1 Ca2+ CHRNA3 GRIA1 Cl- Na+ADCY9 NMDA receptor ligandcomplexCHRNA2 GABRA2 Ca2+ADCY8 phospho-CaMKIV:Calmodulinp-T287-CAMK2D CHRNA1 GRIA3 ADCY1 Gly PRKCA GABRA4 RASGRF2 GRIA4 HTR3D p-T287-CAMK2G GNG12 GRIP1/GRIP2Ca/calmodulinactivated AdenylateCyclaseGNG4 GNAI2 Ca2+GABA ADPAP2M1-2 GNB1 GTP KCNJ9 GNAI1 ADPGABBR2 GABRA5 GRIA2 CHRNB3 GRIP1/GRIP2Cl- RPS6KA2 GNG8 ADCY4 O-acteylcholinebound to calciumpermeablepostsynapticnicotinicacetylcholinereceptorsADCY9 Ca permeable AMPAreceptorsGNG8 p-S360,S377,T570-RPS6KA2 GNAL DLG4 GNG5 GDP ADCY3 GNAL GDP GRIK2 CaMKIIADCY5 GDP CHRNA9 GRIN2B PPiCHRNE GNGT2 PSD-95 GRIN2A GRIK1 AKAP9 CHRNA4 Na+GABA ATPADCY5 GRIA4 GRIN2A ATPADPK+p-T286-CAMK2A ADCY7 ADCY4 GNAI3 ATPCa impermeable AMPAreceptorsp-T287-CAMK2G K+GTP PSD-95 CAMK2heteromer:CALM:4xCa2+Ca2+G alpha-olf:GDPcomplexPSD-95 GRIA4 GNGT2 GNB5 PS Activatedconventionalprotein kinase CGRIA3 CaMKIIGNAI2 AcChoADCY8 HTR3E Highly calciumpermeablepostsynaptic nicotinicacetylcholinereceptorsGRIN2B PSD-95 Ca2+ p-T287-CAMK2D CAMK4 GRIA1 p-T287-CAMK2G NPTN GRIN2C ADCY3 PLCB2 RASGRF1 AcCho GRIA2 AP2A2-3 CHRNA3 GABRB3 GNB2 ATPGRIA1 AP2 complexATPGRIK3 GRIA4 CHRNB4 p-T287-CAMK2B AP2A1 PSD-95 Ca2+ATPKainatereceptor-glutamate-Gprotein complexGly GNB2 p-S218,S360,S377,T570-RPS6KA2 CACNG8 RRAS Cl- p-T185,Y187-MAPK1PLCB3 GRIN1 CHRNA3 GRIN2D GABRheteropentamers:GABAADCY3 p-T286-CAMK2A PiCACNG4 GNAI1 (Gialpha1:GDP:Adenylate cyclase):(G alpha-olf:GDP)CHRNG ADP CHRNA6 Na+TSPAN7 Ca2+ GRIA1 CHRNA6 GTP GNG3 GRIA1 GNG10 GABRB3 GLRA1 CHRNA2 Cl- CHRNA5 PiADCY7 GRIA1 GRIN2B L-Glu GRIK3 homomerglutamate complexNa+CALM1 CREB1ATPGNG13 AP2ACa2+CHRNA1 GRIA4 Activated B-rafcomplexNa+HTR3C Mg2+ G-protein alpha(i):GTP:AdenylatecyclaseACTN2 GRIN1 CACNG2 GABRB2 GNGT1 Edited KainatereceptorsGLRA4 GRIA3 NMDA receptorcomplexp-T287-CAMK2B PLCB2 RPS6KA3 Calmodulin:CaMK IVADCY4 GABRR3 BRAF GNG4 Ribosomal S6 kinaseGABRB1 p-T287-CAMK2B Mg2+GABBR1 GRIN1 GRIN2B DLG3 GNB2 Cl-ADCY6 L-Glu GTP GNB3 Cl-GNG13 GRIN2A ADCY4 CHRNB4 p-S133-CREB1GNAL p-T286-CAMK2A p-CAMKK1ADP GABRG2 GNG12 GNAT3 L-Glu ADCY9 GRIN2C GNG10 p-T286-CAMK2A L-Glu CHRNA3 GABRA4 GRIN2D GNG8 G alpha-olf:GTPCAMK2 heteromerADCY1 ADCY7 GRIK2 GABAB receptorGTP Ca2+RasGRFCHRNG EPB41L1CHRNB4 ADCY3 GABRG2 p-S363,S380,T573-RPS6KA1 GRIA1 PLCB1 ADPGRIA2 CHRNB3 GNGT2 GLRB ADCY3 KCNJ4 CHRNA1 p-T287-CAMK2G CALM1 CHRNA7 GNAI1 PLCB1 ADPPRKCB ATPRPS6KA6 CHRNB4 GNG10 CHRNA1 CAMKK1ADPCa2+DAG 762766


Description

The neurotransmitter in the synaptic cleft released by the pre-synaptic neuron binds specific receptors located on the post-synaptic terminal. These receptors are either ion channels or G protein coupled receptors that function to transmit the signals from the post-synaptic membrane to the cell body. View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 112314
Reactome-version 
Reactome version: 65
Reactome Author 
Reactome Author: Mahajan, SS

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Hardingham GE, Bading H.; ''Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.''; PubMed Europe PMC Scholia
  2. Bettler B, Kaupmann K, Mosbacher J, Gassmann M.; ''Molecular structure and physiological functions of GABA(B) receptors.''; PubMed Europe PMC Scholia
  3. Steinlein OK, Bertrand D.; ''Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases.''; PubMed Europe PMC Scholia
  4. Kessels HW, Malinow R.; ''Synaptic AMPA receptor plasticity and behavior.''; PubMed Europe PMC Scholia
  5. Jane DE, Lodge D, Collingridge GL.; ''Kainate receptors: pharmacology, function and therapeutic potential.''; PubMed Europe PMC Scholia
  6. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M.; ''Structural and functional diversity of native brain neuronal nicotinic receptors.''; PubMed Europe PMC Scholia
  7. Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.; ''Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.''; PubMed Europe PMC Scholia
  8. Barnes NM, Hales TG, Lummis SC, Peters JA.; ''The 5-HT3 receptor--the relationship between structure and function.''; PubMed Europe PMC Scholia
  9. Wu ZS, Cheng H, Jiang Y, Melcher K, Xu HE.; ''Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery.''; PubMed Europe PMC Scholia
  10. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S.; ''Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.''; PubMed Europe PMC Scholia
  11. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW.; ''Mammalian nicotinic acetylcholine receptors: from structure to function.''; PubMed Europe PMC Scholia
  12. Pinard A, Seddik R, Bettler B.; ''GABAB receptors: physiological functions and mechanisms of diversity.''; PubMed Europe PMC Scholia
  13. Michels G, Moss SJ.; ''GABAA receptors: properties and trafficking.''; PubMed Europe PMC Scholia
  14. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R.; ''Glutamate receptor ion channels: structure, regulation, and function.''; PubMed Europe PMC Scholia
  15. Cull-Candy S, Kelly L, Farrant M.; ''Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond.''; PubMed Europe PMC Scholia
  16. Itier V, Bertrand D.; ''Neuronal nicotinic receptors: from protein structure to function.''; PubMed Europe PMC Scholia
  17. Padgett CL, Slesinger PA.; ''GABAB receptor coupling to G-proteins and ion channels.''; PubMed Europe PMC Scholia
  18. Handford CA, Lynch JW, Baker E, Webb GC, Ford JH, Sutherland GR, Schofield PR.; ''The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes.''; PubMed Europe PMC Scholia
  19. Paoletti P, Bellone C, Zhou Q.; ''NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.''; PubMed Europe PMC Scholia
  20. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF.; ''The 5-HT3B subunit is a major determinant of serotonin-receptor function.''; PubMed Europe PMC Scholia
  21. Cohen S, Greenberg ME.; ''Communication between the synapse and the nucleus in neuronal development, plasticity, and disease.''; PubMed Europe PMC Scholia
  22. Barrera NP, Herbert P, Henderson RM, Martin IL, Edwardson JM.; ''Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors.''; PubMed Europe PMC Scholia
  23. Grenningloh G, Schmieden V, Schofield PR, Seeburg PH, Siddique T, Mohandas TK, Becker CM, Betz H.; ''Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes.''; PubMed Europe PMC Scholia
  24. Moss SJ, Smart TG.; ''Constructing inhibitory synapses.''; PubMed Europe PMC Scholia
  25. Nikolic Z, Laube B, Weber RG, Lichter P, Kioschis P, Poustka A, Mülhardt C, Becker CM.; ''The human glycine receptor subunit alpha3. Glra3 gene structure, chromosomal localization, and functional characterization of alternative transcripts.''; PubMed Europe PMC Scholia
  26. Lee HK.; ''Synaptic plasticity and phosphorylation.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
118519view10:04, 28 May 2021EweitzOntology Term : 'neuron-to-neuron signaling pathway via the chemical synapse' added !
114633view16:09, 25 January 2021ReactomeTeamReactome version 75
113081view11:14, 2 November 2020ReactomeTeamReactome version 74
112315view15:23, 9 October 2020ReactomeTeamReactome version 73
101214view11:11, 1 November 2018ReactomeTeamreactome version 66
100752view20:36, 31 October 2018ReactomeTeamreactome version 65
100296view19:13, 31 October 2018ReactomeTeamreactome version 64
99842view15:57, 31 October 2018ReactomeTeamreactome version 63
99399view14:34, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
94502view09:18, 14 September 2017Mkutmonreactome version 61
86651view09:23, 11 July 2016ReactomeTeamreactome version 56
83166view10:15, 18 November 2015ReactomeTeamVersion54
81530view13:04, 21 August 2015ReactomeTeamVersion53
77001view08:29, 17 July 2014ReactomeTeamFixed remaining interactions
76706view12:07, 16 July 2014ReactomeTeamFixed remaining interactions
76032view10:09, 11 June 2014ReactomeTeamRe-fixing comment source
75741view11:22, 10 June 2014ReactomeTeamReactome 48 Update
75091view14:04, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74738view08:49, 30 April 2014ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
(Gi alpha1:GDP:Adenylate cyclase):(G alpha-olf:GDP)ComplexR-HSA-170656 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GDP)ComplexR-HSA-170659 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)ComplexR-HSA-170683 (Reactome)
0-acteylcholine

bound to calcium permeable nictonic acteylcholine

receptor complex
ComplexR-HSA-629600 (Reactome)
5HT MetaboliteCHEBI:28790 (ChEBI)
ACTN2 ProteinP35609 (Uniprot-TrEMBL)
ADCY1 ProteinQ08828 (Uniprot-TrEMBL)
ADCY2 ProteinQ08462 (Uniprot-TrEMBL)
ADCY3 ProteinO60266 (Uniprot-TrEMBL)
ADCY4 ProteinQ8NFM4 (Uniprot-TrEMBL)
ADCY5 ProteinO95622 (Uniprot-TrEMBL)
ADCY6 ProteinO43306 (Uniprot-TrEMBL)
ADCY7 ProteinP51828 (Uniprot-TrEMBL)
ADCY8 ProteinP40145 (Uniprot-TrEMBL)
ADCY9 ProteinO60503 (Uniprot-TrEMBL)
ADP MetaboliteCHEBI:16761 (ChEBI)
ADPMetaboliteCHEBI:16761 (ChEBI)
AKAP5ProteinP24588 (Uniprot-TrEMBL)
AKAP9 ProteinQ99996 (Uniprot-TrEMBL)
AP2 complexComplexR-HSA-416629 (Reactome)
AP2A1 ProteinO95782 (Uniprot-TrEMBL)
AP2A2-3 ProteinO94973-3 (Uniprot-TrEMBL)
AP2AComplexR-HSA-416640 (Reactome)
AP2B1-1 ProteinP63010-1 (Uniprot-TrEMBL)
AP2M1-2 ProteinQ96CW1-2 (Uniprot-TrEMBL)
AP2S1-1 ProteinP53680-1 (Uniprot-TrEMBL)
ARHGEF9 ProteinO43307 (Uniprot-TrEMBL)
ATPMetaboliteCHEBI:15422 (ChEBI)
AcCho MetaboliteCHEBI:15355 (ChEBI)
AcChoMetaboliteCHEBI:15355 (ChEBI)
Activated

conventional

protein kinase C
ComplexR-HSA-139830 (Reactome)
Activated B-raf complexComplexR-HSA-1063697 (Reactome)
Adenylate cyclase (Mg2+ cofactor)ComplexR-HSA-170665 (Reactome)
BRAF ProteinP15056 (Uniprot-TrEMBL)
CACNG2 ProteinQ9Y698 (Uniprot-TrEMBL)
CACNG3 ProteinO60359 (Uniprot-TrEMBL)
CACNG4 ProteinQ9UBN1 (Uniprot-TrEMBL)
CACNG8 ProteinQ8WXS5 (Uniprot-TrEMBL)
CALM1 ProteinP0DP23 (Uniprot-TrEMBL)
CALM1:4xCa2+ComplexR-HSA-74294 (Reactome)
CALM1ProteinP0DP23 (Uniprot-TrEMBL)
CAMK2 heteromer:CALM:4xCa2+ComplexR-HSA-444601 (Reactome)
CAMK2 heteromerComplexR-HSA-432792 (Reactome) CaMKII is composed of a homo or hetero dodecamer of four subunits apha, beta, delta and gamma. In a heteromultimer the ratio of alpha to beta may vary from 6;1, 3:1 or 1:1.
CAMK4 ProteinQ16566 (Uniprot-TrEMBL)
CAMK4ProteinQ16566 (Uniprot-TrEMBL)
CAMKK1ProteinQ8N5S9 (Uniprot-TrEMBL)
CHRNA1 ProteinP02708 (Uniprot-TrEMBL)
CHRNA2 ProteinQ15822 (Uniprot-TrEMBL)
CHRNA3 ProteinP32297 (Uniprot-TrEMBL)
CHRNA4 ProteinP43681 (Uniprot-TrEMBL)
CHRNA5 ProteinP30532 (Uniprot-TrEMBL)
CHRNA6 ProteinQ15825 (Uniprot-TrEMBL)
CHRNA7 ProteinP36544 (Uniprot-TrEMBL)
CHRNA9 ProteinQ9UGM1 (Uniprot-TrEMBL)
CHRNB2 ProteinP17787 (Uniprot-TrEMBL)
CHRNB3 ProteinQ05901 (Uniprot-TrEMBL)
CHRNB4 ProteinP30926 (Uniprot-TrEMBL)
CHRND ProteinQ07001 (Uniprot-TrEMBL)
CHRNE ProteinQ04844 (Uniprot-TrEMBL)
CHRNG ProteinP07510 (Uniprot-TrEMBL)
CREB1ProteinP16220 (Uniprot-TrEMBL)
Ca impermeable AMPA

receptor ligand

complex
ComplexR-HSA-420974 (Reactome)
Ca impermeable AMPA

receptors (with

phospho GluR2 S880)
ComplexR-HSA-421001 (Reactome)
Ca impermeable AMPA receptorsComplexR-HSA-399713 (Reactome)
Ca impermeable AMPA receptorsComplexR-HSA-416323 (Reactome)
Ca permeable AMPA

receptor ligand

complex
ComplexR-HSA-420976 (Reactome)
Ca permeable AMPA receptorsComplexR-HSA-399714 (Reactome)
Ca permeable AMPA receptorsComplexR-HSA-416325 (Reactome)
Ca/calmodulin

activated Adenylate

Cyclase
ComplexR-HSA-443461 (Reactome)
Ca2+ MetaboliteCHEBI:29108 (ChEBI)
Ca2+MetaboliteCHEBI:29108 (ChEBI)
CaMKIIComplexR-HSA-417004 (Reactome) CaMKII is composed of a homo or hetero dodecamer of four subunits apha, beta, delta and gamma. In a heteromultimer the ratio of alpha to beta may vary from 6;1, 3:1 or 1:1.
CaMKIIComplexR-HSA-444796 (Reactome)
CaMKIIComplexR-HSA-445374 (Reactome)
Calmodulin:CaMK IVComplexR-HSA-111900 (Reactome)
Calmodulin:CaMK IVComplexR-HSA-112281 (Reactome)
Cl- MetaboliteCHEBI:17996 (ChEBI)
Cl-MetaboliteCHEBI:17996 (ChEBI)
DAG MetaboliteCHEBI:17815 (ChEBI)
DLG1 ProteinQ12959 (Uniprot-TrEMBL)
DLG1ProteinQ12959 (Uniprot-TrEMBL)
DLG3 ProteinQ92796 (Uniprot-TrEMBL)
DLG4 ProteinP78352 (Uniprot-TrEMBL)
EPB41L1ProteinQ9H4G0 (Uniprot-TrEMBL)
Edited GRIK 1 (GluR5) ProteinP39086 (Uniprot-TrEMBL) Glutamine at position 636 is replaced by arginine in an editing step which occurs posttranscriptionally.
Edited GRIK2 (GluR6) ProteinQ13002 (Uniprot-TrEMBL) GRIK2 is edited at the Q/R site at 621 where the glutamine is edited to arginine. GRIK2 is also edited at 571 (Y/C) where a tyrosine residue is changed to cysteine and 567 (I/V) where an isoleucine is changed to valine. All three sites are edited postranscriptionally. A fully edited GRIK2 at all three sites is totally impermeable to calcium ions.
Edited Kainate

Receptor-glutamate

complex
ComplexR-HSA-451304 (Reactome)
Edited Kainate receptorsComplexR-HSA-451279 (Reactome) Kainate receptors are formed by the assembly of four subunits. GluR5-7 (GRIK, glutamate receptor, ionotropic Kainate 1-3) form functional homomers whereas, KA1 and KA2 or GRIK4,5 form functional heteromers with GRIK1/2/3. Kainate receptor subunits bind Cl- ion in the anion binding site in the ligand binding domain. The dimer is stabilized by the presence of one Cl- ion which binds within the dimer interface.
G alpha (i): GTPComplexR-HSA-392161 (Reactome)
G alpha-olf:GDP complexComplexR-HSA-170669 (Reactome)
G alpha-olf:GTPComplexR-HSA-170661 (Reactome)
G-protein

beta-gamma:PLC beta

1/2/3
ComplexR-HSA-398037 (Reactome)
G-protein alpha (i):GDPComplexR-HSA-392164 (Reactome)
G-protein alpha

(i):GTP:Adenylate

cyclase
ComplexR-HSA-396910 (Reactome)
GABA B receptor

G-protein beta-gamma and Kir3

channel complex
ComplexR-HSA-1013011 (Reactome)
GABA MetaboliteCHEBI:59888 (ChEBI)
GABAB receptor:GABAComplexR-HSA-420698 (Reactome)
GABAB receptorComplexR-HSA-420748 (Reactome)
GABAMetaboliteCHEBI:59888 (ChEBI)
GABBR1 ProteinQ9UBS5 (Uniprot-TrEMBL)
GABBR2 ProteinO75899 (Uniprot-TrEMBL)
GABR heteropentamers:GABA:NPTNComplexR-HSA-8856431 (Reactome)
GABR heteropentamers:GABAComplexR-HSA-975268 (Reactome)
GABRA1 ProteinP14867 (Uniprot-TrEMBL)
GABRA2 ProteinP47869 (Uniprot-TrEMBL)
GABRA3 ProteinP34903 (Uniprot-TrEMBL)
GABRA4 ProteinP48169 (Uniprot-TrEMBL)
GABRA5 ProteinP31644 (Uniprot-TrEMBL)
GABRA6 ProteinQ16445 (Uniprot-TrEMBL)
GABRB1 ProteinP18505 (Uniprot-TrEMBL)
GABRB2 ProteinP47870 (Uniprot-TrEMBL)
GABRB3 ProteinP28472 (Uniprot-TrEMBL)
GABRG2 ProteinP18507 (Uniprot-TrEMBL)
GABRG3 ProteinQ99928 (Uniprot-TrEMBL)
GABRQ ProteinQ9UN88 (Uniprot-TrEMBL)
GABRR pentamer:GABAComplexR-HSA-975448 (Reactome)
GABRR1 ProteinP24046 (Uniprot-TrEMBL)
GABRR2 ProteinP28476 (Uniprot-TrEMBL)
GABRR3 ProteinA8MPY1 (Uniprot-TrEMBL)
GDP MetaboliteCHEBI:17552 (ChEBI)
GLRA1 ProteinP23415 (Uniprot-TrEMBL)
GLRA2 ProteinP23416 (Uniprot-TrEMBL)
GLRA3 ProteinO75311 (Uniprot-TrEMBL)
GLRA4 ProteinQ5JXX5 (Uniprot-TrEMBL)
GLRA:GLRB:GlyComplexR-HSA-975385 (Reactome)
GLRB ProteinP48167 (Uniprot-TrEMBL)
GNAI1 ProteinP63096 (Uniprot-TrEMBL)
GNAI2 ProteinP04899 (Uniprot-TrEMBL)
GNAI3 ProteinP08754 (Uniprot-TrEMBL)
GNAL ProteinP38405 (Uniprot-TrEMBL)
GNAT3 ProteinA8MTJ3 (Uniprot-TrEMBL)
GNB1 ProteinP62873 (Uniprot-TrEMBL)
GNB2 ProteinP62879 (Uniprot-TrEMBL)
GNB3 ProteinP16520 (Uniprot-TrEMBL)
GNB4 ProteinQ9HAV0 (Uniprot-TrEMBL)
GNB5 ProteinO14775 (Uniprot-TrEMBL)
GNG10 ProteinP50151 (Uniprot-TrEMBL)
GNG11 ProteinP61952 (Uniprot-TrEMBL)
GNG12 ProteinQ9UBI6 (Uniprot-TrEMBL)
GNG13 ProteinQ9P2W3 (Uniprot-TrEMBL)
GNG2 ProteinP59768 (Uniprot-TrEMBL)
GNG3 ProteinP63215 (Uniprot-TrEMBL)
GNG4 ProteinP50150 (Uniprot-TrEMBL)
GNG5 ProteinP63218 (Uniprot-TrEMBL)
GNG7 ProteinO60262 (Uniprot-TrEMBL)
GNG8 ProteinQ9UK08 (Uniprot-TrEMBL)
GNGT1 ProteinP63211 (Uniprot-TrEMBL)
GNGT2 ProteinO14610 (Uniprot-TrEMBL)
GRIA1 ProteinP42261 (Uniprot-TrEMBL)
GRIA2 ProteinP42262 (Uniprot-TrEMBL)
GRIA3 ProteinP42263 (Uniprot-TrEMBL)
GRIA4 ProteinP48058 (Uniprot-TrEMBL)
GRIK 3 homomerComplexR-HSA-450196 (Reactome)
GRIK1 ProteinP39086 (Uniprot-TrEMBL)
GRIK2 ProteinQ13002 (Uniprot-TrEMBL)
GRIK3 ProteinQ13003 (Uniprot-TrEMBL)
GRIK3 homomer glutamate complexComplexR-HSA-500705 (Reactome)
GRIK4 ProteinQ16099 (Uniprot-TrEMBL)
GRIK5 ProteinQ16478 (Uniprot-TrEMBL)
GRIN1 ProteinQ05586 (Uniprot-TrEMBL)
GRIN2A ProteinQ12879 (Uniprot-TrEMBL)
GRIN2B ProteinQ13224 (Uniprot-TrEMBL)
GRIN2C ProteinQ14957 (Uniprot-TrEMBL)
GRIN2D ProteinO15399 (Uniprot-TrEMBL)
GRIP1 ProteinQ9Y3R0 (Uniprot-TrEMBL)
GRIP1/GRIP2ComplexR-HSA-416631 (Reactome)
GRIP1/GRIP2ComplexR-HSA-416636 (Reactome)
GRIP2 ProteinQ9C0E4 (Uniprot-TrEMBL)
GTP MetaboliteCHEBI:15996 (ChEBI)
Gly MetaboliteCHEBI:57305 (ChEBI)
GlyMetaboliteCHEBI:57305 (ChEBI)
HRAS ProteinP01112 (Uniprot-TrEMBL)
HRAS:GDPComplexR-HSA-206896 (Reactome)
HRAS:GTPComplexR-HSA-206946 (Reactome)
HTR3 pentamer:5HTComplexR-HSA-975348 (Reactome)
HTR3A ProteinP46098 (Uniprot-TrEMBL)
HTR3B ProteinO95264 (Uniprot-TrEMBL)
HTR3C ProteinQ8WXA8 (Uniprot-TrEMBL)
HTR3D ProteinQ70Z44 (Uniprot-TrEMBL)
HTR3E ProteinA5X5Y0 (Uniprot-TrEMBL)
Highly calcium

permeable postsynaptic nicotinic acetylcholine

receptors
ComplexR-HSA-629581 (Reactome)
Highly calcium

permeable nicotinic acetylcholine

receptors
ComplexR-HSA-629586 (Reactome)
Highly sodium

permeable nicotinic acetylcholine

receptors
ComplexR-HSA-629576 (Reactome)
K+MetaboliteCHEBI:29103 (ChEBI)
KCNJ10 ProteinP78508 (Uniprot-TrEMBL)
KCNJ12 ProteinQ14500 (Uniprot-TrEMBL)
KCNJ15 ProteinQ99712 (Uniprot-TrEMBL)
KCNJ16 ProteinQ9NPI9 (Uniprot-TrEMBL)
KCNJ2 ProteinP63252 (Uniprot-TrEMBL)
KCNJ3 ProteinP48549 (Uniprot-TrEMBL)
KCNJ4 ProteinP48050 (Uniprot-TrEMBL)
KCNJ5 ProteinP48544 (Uniprot-TrEMBL)
KCNJ6 ProteinP48051 (Uniprot-TrEMBL)
KCNJ9 ProteinQ92806 (Uniprot-TrEMBL)
Kainate

receptor-glutamate

complex
ComplexR-HSA-451281 (Reactome)
Kainate receptor-glutamate-Gprotein complexComplexR-HSA-500703 (Reactome)
Kainate ReceptorsComplexR-HSA-450885 (Reactome) Kainate receptors are formed by the assembly of four subunits. GluR5-7 (GRIK, glutamate receptor, ionotropic Kainate 1-3) form functional homomers whereas, KA1 and KA2 or GRIK4,5 form functional heteromers with GRIK1/2/3. Kainate receptor subunits bind Cl- ion in the anion binding site in the ligand binding domain. The dimer is stabilized by the presence of one Cl- ion which binds within the dimer interface.
L-Glu MetaboliteCHEBI:29985 (ChEBI)
L-GluMetaboliteCHEBI:29985 (ChEBI)
MAPK1ProteinP28482 (Uniprot-TrEMBL)
MDM2 ProteinQ00987 (Uniprot-TrEMBL)
MYO6ProteinQ9UM54 (Uniprot-TrEMBL)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
Mg2+MetaboliteCHEBI:18420 (ChEBI)
NCALD ProteinP61601 (Uniprot-TrEMBL)
NEFL ProteinP07196 (Uniprot-TrEMBL)
NMDA receptor complexComplexR-HSA-419566 (Reactome) NMDAR complex consists of two NR1 subunits and two NR2 subunits. Each subunit has extensive C terminal tail that is modified by series of protein kinases and protein phosphatases. The NR1 subunits binds co-agonist glycine while the NR2 subunit binds glutamate. Hence the activation of NR1/NR2 containing NMDA receptor complexes are activated upon depolarization of the membrane and binding of both glycine and glutamate. The dual requirement of membrane depolarization and agonist binding facilitate coincidence detection by NMDA receptors that ensures activation of both pre-synaptic and post-synaptic cell. NR1/NR2 containing NMDA receptors are highly Ca2+ permeable and subjected to a voltage dependent Mg2+ block.
NMDA receptor ligand complexComplexR-HSA-432783 (Reactome)
NMDA receptor-Mg complexComplexR-HSA-438039 (Reactome)
NPTN ProteinQ9Y639 (Uniprot-TrEMBL)
NPTNProteinQ9Y639 (Uniprot-TrEMBL)
NSFProteinP46459 (Uniprot-TrEMBL)
Na+MetaboliteCHEBI:29101 (ChEBI)
O-Acetylcholine

bound to Acetylcholine

receptor
ComplexR-HSA-629590 (Reactome)
O-acteylcholine

bound to calcium permeable postsynaptic nicotinic acetylcholine

receptors
ComplexR-HSA-629592 (Reactome)
PDPK1ProteinO15530 (Uniprot-TrEMBL)
PICK1 ProteinQ9NRD5 (Uniprot-TrEMBL)
PICK1ProteinQ9NRD5 (Uniprot-TrEMBL)
PLCB1 ProteinQ9NQ66 (Uniprot-TrEMBL)
PLCB2 ProteinQ00722 (Uniprot-TrEMBL)
PLCB3 ProteinQ01970 (Uniprot-TrEMBL)
PPiMetaboliteCHEBI:29888 (ChEBI)
PRKACA ProteinP17612 (Uniprot-TrEMBL)
PRKACB ProteinP22694 (Uniprot-TrEMBL)
PRKACB-like proteinsComplexR-HSA-4127466 (Reactome) This CandidateSet contains sequences identified by William Pearson's analysis of Reactome catalyst entities. Catalyst entity sequences were used to identify analagous sequences that shared overall homology and active site homology. Sequences in this Candidate set were identified in an April 24, 2012 analysis.
PRKACG ProteinP22612 (Uniprot-TrEMBL)
PRKCA ProteinP17252 (Uniprot-TrEMBL)
PRKCB ProteinP05771 (Uniprot-TrEMBL)
PRKCG ProteinP05129 (Uniprot-TrEMBL)
PS MetaboliteCHEBI:18303 (ChEBI)
PSD-95 ProteinP78352 (Uniprot-TrEMBL)
Phospho(S221,S363,S380,T573)- ribosomal S6 kinaseComplexR-HSA-444291 (Reactome)
Phospho(S363,S380,T573)- ribosomal S6 kinaseComplexR-HSA-444261 (Reactome)
Phospho(S363,S380,T573)-ribosomal S6 kinaseComplexR-HSA-445403 (Reactome)
PiMetaboliteCHEBI:18367 (ChEBI)
RASGRF1 ProteinQ13972 (Uniprot-TrEMBL)
RASGRF2 ProteinO14827 (Uniprot-TrEMBL)
RPS6KA1 ProteinQ15418 (Uniprot-TrEMBL)
RPS6KA2 ProteinQ15349 (Uniprot-TrEMBL)
RPS6KA3 ProteinP51812 (Uniprot-TrEMBL)
RPS6KA6 ProteinQ9UK32 (Uniprot-TrEMBL)
RRAS ProteinP10301 (Uniprot-TrEMBL)
RasGRF:Ca/calmodulinComplexR-HSA-442735 (Reactome)
RasGRFComplexR-HSA-442734 (Reactome)
RasGTP-B raf compexComplexR-HSA-1063687 (Reactome)
Ribosomal S6 kinaseComplexR-HSA-444247 (Reactome)
TARP-PSD95-Mdm2ComplexR-HSA-416329 (Reactome)
TARP-PSD95-Mdm2ComplexR-HSA-416851 (Reactome)
TSPAN7 ProteinP41732 (Uniprot-TrEMBL)
TSPAN7:PICK1ComplexR-HSA-8858433 (Reactome)
cAMPMetaboliteCHEBI:17489 (ChEBI)
p-CAMKK1ProteinQ8N5S9 (Uniprot-TrEMBL)
p-S12,S13-CAMK4 ProteinQ16566 (Uniprot-TrEMBL)
p-S133-CREB1ProteinP16220 (Uniprot-TrEMBL)
p-S218,S360,S377,T570-RPS6KA2 ProteinQ15349 (Uniprot-TrEMBL)
p-S221,S363,S380,T573-RPS6KA1 ProteinQ15418 (Uniprot-TrEMBL)
p-S227,S369,S386,T573-RPS6KA3 ProteinP51812 (Uniprot-TrEMBL)
p-S232,S372,S389,T581-RPS6KA6 ProteinQ9UK32 (Uniprot-TrEMBL)
p-S338-BRAF ProteinP15056 (Uniprot-TrEMBL)
p-S338-RAF1ProteinP04049 (Uniprot-TrEMBL)
p-S360,S377,T570-RPS6KA2 ProteinQ15349 (Uniprot-TrEMBL)
p-S363,S380,T573-RPS6KA1 ProteinQ15418 (Uniprot-TrEMBL)
p-S369,S386,T573-RPS6KA3 ProteinP51812 (Uniprot-TrEMBL)
p-S372,S389,T581-RPS6KA6 ProteinQ9UK32 (Uniprot-TrEMBL)
p-S880-GRIA2 ProteinP42262 (Uniprot-TrEMBL)
p-T185,Y187-MAPK1ProteinP28482 (Uniprot-TrEMBL)
p-T286-CAMK2A ProteinQ9UQM7 (Uniprot-TrEMBL)
p-T287-CAMK2B ProteinQ13554 (Uniprot-TrEMBL)
p-T287-CAMK2D ProteinQ13557 (Uniprot-TrEMBL)
p-T287-CAMK2G ProteinQ13555 (Uniprot-TrEMBL)
phospho-CaMK IV:CalmodulinComplexR-HSA-111904 (Reactome)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
(Gi alpha1:GDP:Adenylate cyclase):(G alpha-olf:GDP)ArrowR-HSA-170686 (Reactome)
(Gi alpha1:GDP:Adenylate cyclase):(G alpha-olf:GDP)R-HSA-170674 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GDP)ArrowR-HSA-170666 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)ArrowR-HSA-170671 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)R-HSA-170666 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)R-HSA-170686 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)mim-catalysisR-HSA-170666 (Reactome)
(Gi alpha1:GTP:Adenylate cyclase):(G alpha-olf:GTP)mim-catalysisR-HSA-170686 (Reactome)
0-acteylcholine

bound to calcium permeable nictonic acteylcholine

receptor complex
ArrowR-HSA-629599 (Reactome)
ADPArrowR-HSA-111915 (Reactome)
ADPArrowR-HSA-416320 (Reactome)
ADPArrowR-HSA-416639 (Reactome)
ADPArrowR-HSA-416985 (Reactome)
ADPArrowR-HSA-421007 (Reactome)
ADPArrowR-HSA-442724 (Reactome)
ADPArrowR-HSA-442726 (Reactome)
ADPArrowR-HSA-442737 (Reactome)
ADPArrowR-HSA-442739 (Reactome)
ADPArrowR-HSA-442749 (Reactome)
ADPArrowR-HSA-443474 (Reactome)
ADPArrowR-HSA-443475 (Reactome)
ADPArrowR-HSA-443480 (Reactome)
ADPArrowR-HSA-444253 (Reactome)
AKAP5ArrowR-HSA-416320 (Reactome)
AKAP5R-HSA-416320 (Reactome)
AP2 complexArrowR-HSA-416639 (Reactome)
AP2 complexR-HSA-416639 (Reactome)
AP2AArrowR-HSA-421007 (Reactome)
AP2AR-HSA-421007 (Reactome)
ATPR-HSA-111915 (Reactome)
ATPR-HSA-416320 (Reactome)
ATPR-HSA-416639 (Reactome)
ATPR-HSA-416985 (Reactome)
ATPR-HSA-421007 (Reactome)
ATPR-HSA-442715 (Reactome)
ATPR-HSA-442724 (Reactome)
ATPR-HSA-442726 (Reactome)
ATPR-HSA-442737 (Reactome)
ATPR-HSA-442739 (Reactome)
ATPR-HSA-442749 (Reactome)
ATPR-HSA-443474 (Reactome)
ATPR-HSA-443475 (Reactome)
ATPR-HSA-443480 (Reactome)
ATPR-HSA-444253 (Reactome)
AcChoR-HSA-629588 (Reactome)
AcChoR-HSA-629596 (Reactome)
AcChoR-HSA-629599 (Reactome)
Activated

conventional

protein kinase C
mim-catalysisR-HSA-416639 (Reactome)
Activated

conventional

protein kinase C
mim-catalysisR-HSA-421007 (Reactome)
Activated B-raf complexArrowR-HSA-442726 (Reactome)
Adenylate cyclase (Mg2+ cofactor)ArrowR-HSA-170674 (Reactome)
Adenylate cyclase (Mg2+ cofactor)R-HSA-392206 (Reactome)
CALM1:4xCa2+R-HSA-111913 (Reactome)
CALM1:4xCa2+R-HSA-442725 (Reactome)
CALM1R-HSA-442760 (Reactome)
CAMK2 heteromer:CALM:4xCa2+ArrowR-HSA-442725 (Reactome)
CAMK2 heteromerR-HSA-442725 (Reactome)
CAMK2 heteromerR-HSA-445367 (Reactome)
CAMK4R-HSA-111913 (Reactome)
CAMKK1R-HSA-442749 (Reactome)
CAMKK1mim-catalysisR-HSA-442749 (Reactome)
CREB1R-HSA-442724 (Reactome)
CREB1R-HSA-443474 (Reactome)
CREB1R-HSA-443475 (Reactome)
CREB1R-HSA-443480 (Reactome)
Ca impermeable AMPA

receptor ligand

complex
ArrowR-HSA-420975 (Reactome)
Ca impermeable AMPA

receptor ligand

complex
R-HSA-399711 (Reactome)
Ca impermeable AMPA

receptors (with

phospho GluR2 S880)
R-HSA-421007 (Reactome)
Ca impermeable AMPA receptorsArrowR-HSA-399711 (Reactome)
Ca impermeable AMPA receptorsArrowR-HSA-416639 (Reactome)
Ca impermeable AMPA receptorsArrowR-HSA-416985 (Reactome)
Ca impermeable AMPA receptorsArrowR-HSA-421007 (Reactome)
Ca impermeable AMPA receptorsArrowR-HSA-438037 (Reactome)
Ca impermeable AMPA receptorsR-HSA-416639 (Reactome)
Ca impermeable AMPA receptorsR-HSA-416985 (Reactome)
Ca impermeable AMPA receptorsR-HSA-420975 (Reactome)
Ca impermeable AMPA receptorsR-HSA-438037 (Reactome)
Ca impermeable AMPA receptorsmim-catalysisR-HSA-399711 (Reactome)
Ca impermeable AMPA receptorsmim-catalysisR-HSA-432162 (Reactome)
Ca impermeable AMPA receptorsmim-catalysisR-HSA-438037 (Reactome)
Ca permeable AMPA

receptor ligand

complex
ArrowR-HSA-420977 (Reactome)
Ca permeable AMPA

receptor ligand

complex
R-HSA-399712 (Reactome)
Ca permeable AMPA

receptor ligand

complex
R-HSA-420980 (Reactome)
Ca permeable AMPA receptorsArrowR-HSA-399712 (Reactome)
Ca permeable AMPA receptorsArrowR-HSA-416320 (Reactome)
Ca permeable AMPA receptorsArrowR-HSA-420980 (Reactome)
Ca permeable AMPA receptorsR-HSA-416320 (Reactome)
Ca permeable AMPA receptorsR-HSA-420977 (Reactome)
Ca permeable AMPA receptorsmim-catalysisR-HSA-399712 (Reactome)
Ca permeable AMPA receptorsmim-catalysisR-HSA-420980 (Reactome)
Ca/calmodulin

activated Adenylate

Cyclase
mim-catalysisR-HSA-442715 (Reactome)
Ca2+ArrowR-HSA-399712 (Reactome)
Ca2+ArrowR-HSA-432164 (Reactome)
Ca2+ArrowR-HSA-442715 (Reactome)
Ca2+ArrowR-HSA-451311 (Reactome)
Ca2+ArrowR-HSA-622326 (Reactome)
Ca2+ArrowR-HSA-629595 (Reactome)
Ca2+ArrowR-HSA-975311 (Reactome)
Ca2+R-HSA-399712 (Reactome)
Ca2+R-HSA-432164 (Reactome)
Ca2+R-HSA-442715 (Reactome)
Ca2+R-HSA-442760 (Reactome)
Ca2+R-HSA-451311 (Reactome)
Ca2+R-HSA-622326 (Reactome)
Ca2+R-HSA-629595 (Reactome)
Ca2+R-HSA-975311 (Reactome)
CaMKIIArrowR-HSA-444792 (Reactome)
CaMKIIArrowR-HSA-445367 (Reactome)
CaMKIIR-HSA-444792 (Reactome)
CaMKIImim-catalysisR-HSA-416320 (Reactome)
CaMKIImim-catalysisR-HSA-442725 (Reactome)
CaMKIImim-catalysisR-HSA-442726 (Reactome)
CaMKIImim-catalysisR-HSA-443475 (Reactome)
Calmodulin:CaMK IVArrowR-HSA-111913 (Reactome)
Calmodulin:CaMK IVArrowR-HSA-112282 (Reactome)
Calmodulin:CaMK IVR-HSA-111915 (Reactome)
Calmodulin:CaMK IVR-HSA-112282 (Reactome)
Calmodulin:CaMK IVmim-catalysisR-HSA-111915 (Reactome)
Calmodulin:CaMK IVmim-catalysisR-HSA-443480 (Reactome)
Cl-ArrowR-HSA-975340 (Reactome)
Cl-ArrowR-HSA-975389 (Reactome)
Cl-ArrowR-HSA-975449 (Reactome)
Cl-R-HSA-975340 (Reactome)
Cl-R-HSA-975389 (Reactome)
Cl-R-HSA-975449 (Reactome)
DLG1ArrowR-HSA-416320 (Reactome)
DLG1R-HSA-416320 (Reactome)
EPB41L1ArrowR-HSA-416320 (Reactome)
EPB41L1R-HSA-416320 (Reactome)
Edited Kainate

Receptor-glutamate

complex
ArrowR-HSA-451309 (Reactome)
Edited Kainate

Receptor-glutamate

complex
R-HSA-451310 (Reactome)
Edited Kainate receptorsArrowR-HSA-451310 (Reactome)
Edited Kainate receptorsR-HSA-451309 (Reactome)
Edited Kainate receptorsmim-catalysisR-HSA-451310 (Reactome)
G alpha (i): GTPR-HSA-392206 (Reactome)
G alpha-olf:GDP complexArrowR-HSA-170674 (Reactome)
G alpha-olf:GTPR-HSA-170671 (Reactome)
G-protein

beta-gamma:PLC beta

1/2/3
R-HSA-500717 (Reactome)
G-protein alpha (i):GDPArrowR-HSA-170674 (Reactome)
G-protein alpha

(i):GTP:Adenylate

cyclase
ArrowR-HSA-392206 (Reactome)
G-protein alpha

(i):GTP:Adenylate

cyclase
R-HSA-170671 (Reactome)
GABA B receptor

G-protein beta-gamma and Kir3

channel complex
mim-catalysisR-HSA-1013020 (Reactome)
GABAB receptor:GABAArrowR-HSA-420688 (Reactome)
GABAB receptorR-HSA-420688 (Reactome)
GABAR-HSA-420688 (Reactome)
GABR heteropentamers:GABA:NPTNArrowR-HSA-8856398 (Reactome)
GABR heteropentamers:GABAR-HSA-8856398 (Reactome)
GABR heteropentamers:GABAmim-catalysisR-HSA-975340 (Reactome)
GABRR pentamer:GABAmim-catalysisR-HSA-975449 (Reactome)
GLRA:GLRB:Glymim-catalysisR-HSA-975389 (Reactome)
GRIK 3 homomerR-HSA-500708 (Reactome)
GRIK3 homomer glutamate complexArrowR-HSA-500708 (Reactome)
GRIK3 homomer glutamate complexR-HSA-500717 (Reactome)
GRIK3 homomer glutamate complexmim-catalysisR-HSA-500717 (Reactome)
GRIP1/GRIP2ArrowR-HSA-416639 (Reactome)
GRIP1/GRIP2ArrowR-HSA-416985 (Reactome)
GRIP1/GRIP2ArrowR-HSA-421007 (Reactome)
GRIP1/GRIP2R-HSA-416639 (Reactome)
GRIP1/GRIP2R-HSA-416985 (Reactome)
GRIP1/GRIP2R-HSA-421007 (Reactome)
GlyR-HSA-432172 (Reactome)
HRAS:GDPR-HSA-442732 (Reactome)
HRAS:GTPArrowR-HSA-442732 (Reactome)
HTR3 pentamer:5HTmim-catalysisR-HSA-975311 (Reactome)
Highly calcium

permeable postsynaptic nicotinic acetylcholine

receptors
ArrowR-HSA-629595 (Reactome)
Highly calcium

permeable postsynaptic nicotinic acetylcholine

receptors
R-HSA-629595 (Reactome)
Highly calcium

permeable postsynaptic nicotinic acetylcholine

receptors
R-HSA-629596 (Reactome)
Highly calcium

permeable postsynaptic nicotinic acetylcholine

receptors
mim-catalysisR-HSA-629595 (Reactome)
Highly calcium

permeable nicotinic acetylcholine

receptors
ArrowR-HSA-622326 (Reactome)
Highly calcium

permeable nicotinic acetylcholine

receptors
R-HSA-622326 (Reactome)
Highly calcium

permeable nicotinic acetylcholine

receptors
R-HSA-629599 (Reactome)
Highly calcium

permeable nicotinic acetylcholine

receptors
mim-catalysisR-HSA-622326 (Reactome)
Highly sodium

permeable nicotinic acetylcholine

receptors
ArrowR-HSA-622325 (Reactome)
Highly sodium

permeable nicotinic acetylcholine

receptors
R-HSA-622325 (Reactome)
Highly sodium

permeable nicotinic acetylcholine

receptors
R-HSA-629588 (Reactome)
Highly sodium

permeable nicotinic acetylcholine

receptors
mim-catalysisR-HSA-622325 (Reactome)
K+ArrowR-HSA-1013020 (Reactome)
K+ArrowR-HSA-975311 (Reactome)
K+R-HSA-1013020 (Reactome)
K+R-HSA-975311 (Reactome)
Kainate

receptor-glutamate

complex
ArrowR-HSA-451283 (Reactome)
Kainate

receptor-glutamate

complex
R-HSA-451311 (Reactome)
Kainate receptor-glutamate-Gprotein complexArrowR-HSA-500717 (Reactome)
Kainate ReceptorsArrowR-HSA-451311 (Reactome)
Kainate ReceptorsR-HSA-451283 (Reactome)
Kainate Receptorsmim-catalysisR-HSA-451311 (Reactome)
L-GluArrowR-HSA-399711 (Reactome)
L-GluArrowR-HSA-399712 (Reactome)
L-GluArrowR-HSA-420980 (Reactome)
L-GluArrowR-HSA-451310 (Reactome)
L-GluArrowR-HSA-451311 (Reactome)
L-GluR-HSA-420975 (Reactome)
L-GluR-HSA-420977 (Reactome)
L-GluR-HSA-432172 (Reactome)
L-GluR-HSA-451283 (Reactome)
L-GluR-HSA-451309 (Reactome)
L-GluR-HSA-500708 (Reactome)
MAPK1R-HSA-442737 (Reactome)
MYO6ArrowR-HSA-416320 (Reactome)
MYO6R-HSA-416320 (Reactome)
Mg2+ArrowR-HSA-432162 (Reactome)
NMDA receptor complexArrowR-HSA-432162 (Reactome)
NMDA receptor complexR-HSA-432172 (Reactome)
NMDA receptor ligand complexArrowR-HSA-432172 (Reactome)
NMDA receptor ligand complexR-HSA-442760 (Reactome)
NMDA receptor ligand complexmim-catalysisR-HSA-432164 (Reactome)
NMDA receptor ligand complexmim-catalysisR-HSA-442760 (Reactome)
NMDA receptor ligand complexmim-catalysisR-HSA-445367 (Reactome)
NMDA receptor-Mg complexR-HSA-432162 (Reactome)
NPTNR-HSA-8856398 (Reactome)
NSFmim-catalysisR-HSA-416985 (Reactome)
Na+ArrowR-HSA-399711 (Reactome)
Na+ArrowR-HSA-420980 (Reactome)
Na+ArrowR-HSA-432162 (Reactome)
Na+ArrowR-HSA-438037 (Reactome)
Na+ArrowR-HSA-451310 (Reactome)
Na+ArrowR-HSA-622325 (Reactome)
Na+ArrowR-HSA-975311 (Reactome)
Na+R-HSA-399711 (Reactome)
Na+R-HSA-420980 (Reactome)
Na+R-HSA-438037 (Reactome)
Na+R-HSA-451310 (Reactome)
Na+R-HSA-622325 (Reactome)
Na+R-HSA-975311 (Reactome)
O-Acetylcholine

bound to Acetylcholine

receptor
ArrowR-HSA-629588 (Reactome)
O-acteylcholine

bound to calcium permeable postsynaptic nicotinic acetylcholine

receptors
ArrowR-HSA-629596 (Reactome)
PDPK1mim-catalysisR-HSA-442739 (Reactome)
PICK1ArrowR-HSA-416639 (Reactome)
PICK1ArrowR-HSA-416985 (Reactome)
PICK1ArrowR-HSA-421007 (Reactome)
PICK1R-HSA-416639 (Reactome)
PICK1R-HSA-416985 (Reactome)
PICK1R-HSA-421007 (Reactome)
PPiArrowR-HSA-442715 (Reactome)
PRKACB-like proteinsmim-catalysisR-HSA-443474 (Reactome)
Phospho(S221,S363,S380,T573)- ribosomal S6 kinaseArrowR-HSA-442739 (Reactome)
Phospho(S221,S363,S380,T573)- ribosomal S6 kinasemim-catalysisR-HSA-442724 (Reactome)
Phospho(S363,S380,T573)- ribosomal S6 kinaseArrowR-HSA-9029434 (Reactome)
Phospho(S363,S380,T573)- ribosomal S6 kinaseR-HSA-442739 (Reactome)
Phospho(S363,S380,T573)-ribosomal S6 kinaseArrowR-HSA-444253 (Reactome)
Phospho(S363,S380,T573)-ribosomal S6 kinaseR-HSA-9029434 (Reactome)
PiArrowR-HSA-170666 (Reactome)
PiArrowR-HSA-170686 (Reactome)
PiArrowR-HSA-416320 (Reactome)
PiArrowR-HSA-416639 (Reactome)
PiArrowR-HSA-421007 (Reactome)
PiR-HSA-416985 (Reactome)
R-HSA-1013020 (Reactome) Binding of G beta gamma activates the GIRK/Kir3 channels that allow the efflux of K+ out of the cell resulting in a hyperpolarized membrane potential. This negative membrane potential prevents the activation of voltage dependent Ca2+ channels.
R-HSA-111913 (Reactome) CaMKIV becomes fully activated after a three-step mechanism: Upon a transient increase in intracellular calcium, calcium-bound calmodulin (Ca2+/CaM) binds to its autoregulatory domain, which relieves intersteric inhibition. An activating protein kinase, calcium/calmodulin-dependent protein kinase kinase (CaMKK), binds to the Ca2+/CaM:CaMKIV complex and phosphorylates CaMKIV on a threonine residue in the activation loop. After full activation by the three-step mechanism mentioned above, the activity of CaMKIV becomes autonomous and no longer requires bound Ca2+/CaM. This activity is required for CaMKIV-mediated transcriptional regulation. The CaMKIV-associated PP2A then dephosphorylates CaMKIV, thereby terminating autonomous activity and CaMKIV-mediated gene transcription.
R-HSA-111915 (Reactome) Autophosphorylation of the N-terminus Ser12-Ser13 is required for full activation after Ca2+/calmodulin binding and phosphorylation of the Ca2+/calmodulin-bound enzyme on Thr200 by a Ca2+/calmodulin-dependent protein kinase kinase.
R-HSA-112282 (Reactome) The calmodulin:CaMK IV complex enters the nucleus.
R-HSA-170666 (Reactome) G proteins can deactivate themselves via their intrinsic GTPase activity, which hydrolyzes GTP to GDP. Effectors such as adenylate cyclase can increase the G protein GTPase rate, acting like GTPase-activating proteins (GAPs).
R-HSA-170671 (Reactome) The chronic activation of mu-opioid receptors, which, when coupled to pertussis toxin-sensitive Galpha-i/o proteins, inhibit adenylyl cyclase (AC).
R-HSA-170674 (Reactome) Once the intrinsic GTPase hydrolyzes GTP to GDP, Galpha-i dissociates from adenylate cyclase, allowing it to re-associate with G-beta-gamma and starting a new cycle.
R-HSA-170686 (Reactome) G proteins can deactivate themselves via their intrinsic GTPase activity, which hydrolyzes GTP to GDP. Effectors such as adenylate cyclase can increase the G protein GTPase rate, acting like GTPase-activating proteins (GAPs).
R-HSA-392206 (Reactome) G-proteins in the Gi class inhibit adenylate cyclase activity, decreasing the production of cAMP from ATP, which has many consequences but classically results in decreased activity of Protein Kinase A (PKA). cAMP also activates the cyclic nucleotide-gated ion channels, a process that is particularly important in olfactory cells.
R-HSA-399711 (Reactome) Each AMPA receptor subunit binds one glutamate molecule in the ligand binding site in the N terminus. Each receptor is capable of binding four glutamate molecules however, channel opens when two sites are occupied by the ligand and the current increases with increased ligand binding. Ca impermeable AMPA receptors containing GluR2 subunit conduct Na currents upon activation by either glutamate binding or agonist, AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) binding. The Na currents mainly lead to depolarization of the membrane leading to activation of voltage gated channels such as NMDA receptors that require both agonist binding and depolarization for their activation.
R-HSA-399712 (Reactome) Each AMPA receptor subunit binds one glutamate molecule in the ligand binding site in the N terminus. Each receptor is capable of binding four glutamate molecule, however, channel opens when two sites are occupied by the ligand and the current increases with increased ligand binding. Ca permeable AMPA receptors containing homomers of GluR1 or heteromers containing GluR1, GluR3 and GluR4 conduct Ca upon glutamate or agonist namely AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) binding. Calcium permeable AMPA receptors conduct Ca and other cations such as Na. The inonic flux leads to Ca or Na currents that leads to either increase in the intracellular Ca concentration leading to further Ca-dependent signaling or increase in depolarization that opens voltage gated channels such as NMDA receptors that require both membrane depolarization and glutamate binding for activation.
R-HSA-416320 (Reactome) GluR1-containing AMPA receptors are delivered to the synapses in an activity dependent manner. GluR1 trafficking is controlled by protein- protein interactions with 4.1N/G protein, SAP97 and by intricate regulation of phosphorylation of GluR1 at several phosphorylation sites in the C tail. GluR1 has four phosphorylation sites; serine 818 (S818) is phosphorylated by PKC, necessary for LTP, serine 831 (S831) is phosphorylated by CaMKII and increases the delivery of receptors to the synapse and also increases their single channel conductance, Threonine (T840) is implicated in LTP and serine 845 (S845) phosphorylated by PKA regulates open channel probability and also by cGKII, a cyclic GMP activated kinase, that increases the surface expression of GluR1. GluR1 insertion into synapse by CaMKII may induce LTP. CaMKII is a Ca/calmodulin dependent kinase that is activated upon increases in the Ca ion concentration during postsynaptic activity through NMDA receptors. The increase in GluR1-containing AMPA receptor population at the synapse results in enhancement of excitatory post synaptic potential (EPSC) which forms the basis of Long term potentiation (LTP). LTP is one form of synaptic plasticity that is involved in memory and learning. The increase in the GluR1 containing AMPA receptors and their activity leads to rise in intracellular Ca which induces signaling pathways that in turn promote switch in the type of AMPA receptors (Ca impermeable) thereby limiting the Ca increase and preventing cell death.
R-HSA-416639 (Reactome) GluR2 containing AMPA receptors are trafficked to the plasmamembrane by the activation of Ca activated PKC that binds PICK.The PICK interaction delivers GluR2 containing AMPA receptors to the Plasmamembrane. This reaction is a part of constitutive recycling of AMPA receptor that delivers the AMPA receptors from the endosome to the plasmamembrane and back to endosome from the plasmamembrane.
R-HSA-416985 (Reactome) Constitutively recycling GluR2 containing AMPA receptors in the plasma membrane are stabilized by the action of NSF ATPase activity which disassociates PICK from GluR2 thereby retaining AMPA receptors in the plasma membrane.
R-HSA-420688 (Reactome) Gamma-aminobutyric acid (GABA) is the chief inhibitory neurotransmitter in the mammalian central nervous system. GABA exerts its effects through two ligand-gated channels and a the GPCR GABAB (Kaupmann K et al, 1998), which acts through G proteins to regulate potassium and calcium channels. GABAB can only bind GABA once it forms a heterodimer composed of the GABABR1 and GABABR2 receptors (White JH et al, 1998). The effects of this dimer are mediated by coupling to the G protein alpha i subunit, which inhibits adenylyl cyclase (Odagaki & Koyama 2001).
R-HSA-420975 (Reactome) AMPA receptors bind glutamate, released in the synaptic cleft by the presynaptic cell, in the ligand binding region in the N terminal domain.
R-HSA-420977 (Reactome) AMPA receptors bind glutamate, released in the synaptic cleft by the presynaptic cell, in the ligand binding region in the N terminal domain.
R-HSA-420980 (Reactome) Each AMPA receptor subunit binds one glutamate molecule in the ligand binding site in the N terminus. Each receptor is capable of binding four glutamate molecule, however, channel opens when two sites are occupied by the ligand and the current increases with increased ligand binding. Ca permeable AMPA receptors containing homomers of GluR1 or heteromers containing GluR1, GluR3 and GluR4 conduct Ca upon glutamate or agonist namely AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) binding. Calcium permeable AMPA receptors conduct Ca and other cations such as Na. The inonic flux leads to Ca or Na currents that leads to either increase in the intracellular Ca concentration leading to further Ca-dependent signaling or increase in depolarization that opens voltage gated channels such as NMDA receptors that require both membrane depolarization and glutamate binding for activation.
R-HSA-421007 (Reactome) GluR2 containing AMPA receptors are constitutively recycled between the endosome membrane and the plasma membrane. GRIP and PICK compete for the binding to the C tail of GluR2. Once the GluR2 containing AMPA receptors are in the plasmamembrane, phosphorylation of GluR2 at S880 by PKC causes disruption of GRIP interaction, but not PICK interaction which facilitates internalization of GluR2 containing AMPA receptors into endosomes.
R-HSA-432162 (Reactome) NMDA receptors are activated in a two step mechanism; first by the removal of the voltage dependent Mg2+ block and then by the ligand dependent activation of the unblocked NMDA receptor. At resting membrane potential NMDA receptors can not be activated by ligand alone due to the presence of Mg2+ ion in the pore of the channel. Due to the activation of other membrane resident channels that allow the influx of Na+ the membrane is depolarized which triggers the removal of Mg2+ form the NMDA receptor pore. Once the Mg2+ is expelled NMDA receptors are ready to be activated by the agonist (glutamate) and the co-agonist (glycine).
R-HSA-432164 (Reactome) NMDA receptors are activated upon binding of two ligands, glutamate and glycine.
The activation leads to Ca2+ influx into the post-synaptic cell. The local rise in the Ca2+ ion concentration further leads to activation of several Ca2+ dependent pathways leading to long term changes in the synapse.
R-HSA-432172 (Reactome) NMDA receptors require binding of two ligands; the agonist, glutamate and co-agonist, glycine. The N terminal extracellular ligand binding domain in NR1 subunits binds co-agonist glycine and the N terminal extracellular ligand binding domain in NR2 binds glutamate.
R-HSA-438037 (Reactome) Membrane depolarization occurs due to glutamate dependent activation of Ca-impermeable AMPA receptors, which permit the influx of Na+ ions. The depolarization triggers the removal of Mg2+ from the NMDA receptor pore to facilitate its activation. Therefore activation of AMPA receptors by glutamate precedes activation of NMDA receptors.
R-HSA-442715 (Reactome) Ca2+ fluxes through NMDA receptors in the post-synaptic neuron facilitate binding of Ca2+/Calmodulin to adenylate cyclase type 1, 3 or 8, resulting in its activation. Once activated, cAMP is produced which further activates PKA.
R-HSA-442724 (Reactome) CREB is phosphorylated at serine 133 by any of the four isoforms of ribosomal S6 kinase.
R-HSA-442725 (Reactome) CaMKII is fully activated upon Ca2+/Calmodulin binding. In addition to Ca2+/Calmodulin activation, CaMKII undergoes multiple autophosphorylation events leading Ca2+/Calmodulin independent activity of the enzyme.
R-HSA-442726 (Reactome) Raf is a downstream effector of ras. Raf is activated upon phosphorylation at S338, oligomerization and membrane localization. Membrane localization is facilitated by ras. Interaction of ras with raf is a necessary step but not sufficient for raf activation. Other unknown protein partner interactions are required for raf activation. Raf further activates MAP kinase.
R-HSA-442732 (Reactome) Binding of RasGRF to Ca2+/Calmodulin in the presence of high Ca2+ leads to the activation of Ras. Activation of Ras involves the exchange of GDP for GTP.
R-HSA-442737 (Reactome) MAPK/ERK is phosphorylated at threonine 185 and tyrosine 187 by membrane associated activated raf kianse leading to the activation of MAPK/ERK kinase. The activated MAPK/ERK in turn activates ribosomal S6 kinase.
R-HSA-442739 (Reactome) PDK1 activates ribosomal S6 kinase (RSK) by phosphorylating S221. The binding site for PDK1 on RSK is available after RSK phosphorylation by MAPK/ERK. PDK1 is present in the activated form at the plasma membrane where the phosphorylation occurs. The activation of RSK occurs in the cytoplasm, plasma membrane and in the nucleus where it finally activates CREB by phosphorylation.
R-HSA-442749 (Reactome) CaMKK is fully activated upon binding Ca2+/Calmodulin after intracellular Ca2+ levels increase. Once CaMKK binds Ca2+/Calmodulin it autophosphorylates, resulting in activation. CaMKK is negatively regulated by phosphorylation of S74 and T108 by PKA. Once activated CaMKK phosphorylates CaMKIV in a Ca2+/Calmodulin dependent manner.
R-HSA-442760 (Reactome) RASGRF is activated upon binding of Ca2+/Calmodulin after Ca2+ influx through the NMDA receptor.
R-HSA-443474 (Reactome) Protein kinase A has two regulatory subunits and two catalytic subunits which are held together to form the holoenzyme and is activated upon binding of cAMP within the regulatory subunits. Once cAMP binds the regulatory subunits, the catalytic subunits are released to carry out phosphorylation of CREB at serine133.
R-HSA-443475 (Reactome) CaMKII is an important regulator of neuronal plasticity. CaMKII shows distinct subcellular localization and acts quickly in a spatio-temporal manner. CaMKII shows fast synaptic localization upon synaptic activity and also nuclear localization, where it phosphorylates CREB at serine 133 to activate transcription of set of genes that results in long lasting structural changes at the synapse.
R-HSA-443480 (Reactome) Activated CaMKIV phosphorylates CREB at S133 thereby initiating the transcription of CREB regulated set of genes leading to protein synthesis and long lasting changes that underlie synaptic plasticity.
R-HSA-444253 (Reactome) Activated MAPK/ERK activates RSK in its C terminal kinase domain by sequentially phosphorylating T573, S363 and 380.
R-HSA-444792 (Reactome) Nuclear targeting of CaMKII depends on several factors including the phosphorylation in the regulatory domain of CaMKII and induction of other signal transduction pathways.
R-HSA-445367 (Reactome) CaMKII gets activated upon Ca2+ influx through the NMDA receptor and moves from plasma membrane to cytoplasm and then nucleus where it phosphorylates CREB at serine 133.
R-HSA-451283 (Reactome) Kainate receptors bind glutamate in the ligand binding domain in the extracellular, N terminal region.
R-HSA-451309 (Reactome) Kainate receptors bind glutamate in the ligand binding domain in the extracellular, N terminal region.
R-HSA-451310 (Reactome) The activation of Kainate receptors by glutamate in the postsynaptic neuron leads to influx of Na+ ions resulting in depolarization of the postsynaptic membrane.
R-HSA-451311 (Reactome) Kainate receptors that are assembled with subunits GRIK1-5, are Ca2+ permeable if GRIK1 and GRIK2 are not edited at the Q/R or other sites.
These channels permit Ca2+ upon activation by glutamate or other agonists.
R-HSA-500708 (Reactome) Kainate receptors bind glutamate in the ligand binding domain in the extracellular, N terminal region.
R-HSA-500717 (Reactome) Kainate receptor activation activates G protein coupled receptors involving the release of Ca2+ from the intracellular stores. This activity of Kainate receptors is independent of ionic influx and regulates both glutamate release by the pyramidal neurons and gama-aminobutyric acid release by the internuerons.
R-HSA-622325 (Reactome) Nicotinic acetylcholine receptors containing aplha4(2) beta2 (3) and alpha3(2) beta4(3) are selectively highly Na+ permeable upon activation of these receptors by acetylcholine.
R-HSA-622326 (Reactome) Nicotinic acetylcholine receptors are activated upon ligand binding which opens the acetylcholine channels and permits Ca2+ and Na+ ion influx depending on the subunit composition and stoichiometry of the subunits. The ratio of Ca2+ to Na+ ion influx varies making the receptors either highly Na+ permeable or Ca2+ permeable.
R-HSA-629588 (Reactome) Nicotinic acetylcholine receptors bind two molecules of ligand, acetylcholine, in the alpha beta interface in receptors containing heteromeric subunits or in the interface of 2 aplha subunits in receptors containing homomeric subunits.
R-HSA-629595 (Reactome) Acetylcholine binding activates postsynaptic acetylchloine receptors that show Ca2+ currents which facilitate the process of long term potentiation (LTP).
R-HSA-629596 (Reactome) Nicotinic acetylcholine receptors bind two molecules of ligand, acetylcholine, in the alpha beta interface in receptors containing heteromeric subunits or in the interface of 2 aplha subunits in receptors containing homomeric subunits.
R-HSA-629599 (Reactome) Nicotinic acetylcholine receptors bind two molecules of ligand, acetylcholine, in the alpha beta interface in receptors containing heteromeric subunits or in the interface of 2 aplha subunits in receptors containing homomeric subunits.
R-HSA-8856398 (Reactome) Neuroplastin (NPTN) is a glycoprotein that belongs to the immunoglobulin (Ig) superfamily of cell adhesion molecules (CAMs). Together with basigin/CD147 and embigin, NPTN comprises the CD147 family (Iacono et al. 2007).

NPTN isoform p65 binds GABAA receptor subunits, co-localizing with alpha1 and alpha2, but not alpha3 subunits at GABAergic synapses and alpha5 subunits at extrasynaptic sites in cultures (Sarto-Jackson et al. 2012). GABAA receptors containing alpha1, 2 or 3 subunits are localized mainly at synaptic sites and interact with the scaffolding protein Gephyrin (GPHN), which anchors the receptor to the underlying postsynaptic complex and prevents their lateral diffusion (Kneussel & Loebrich 2007, Tretter et al. 2012). Receptors containing the alpha5 subunit are mainly extrasynaptic and link to the actin cytoskeleton via Radixin (Loebrich et al. 2006). NPTN p65 co-localization can be at several synaptic sites along the same dendrite, while absent from others. NPTN p65 shRNA caused diffuse alpha2 subunit staining which did not co-localize with vesicular inhibitory aa transporter, a presynaptic marker of GABAergic synapses (Sarto-Jackson et al. 2012). This suggests a functional role for NPTN p65 in regulating the composition and localization of GABAA receptors (Beesley et al. 2014). The absence of NPTN p65 causes early-onset sensorineural hearing loss and prevents normal synaptogenesis in cochleal inner hair cells (IHCs) (Carrott et al. 2016).
R-HSA-9029434 (Reactome) Activation of RS6K by MAPK is required for its translocation to the plasma membrane and for subsequent translocation to the nucleus, where it phosphorylates targets such as CREB1 (Richards et al, 2001; Smith et al, 1999; reviewed in Anjum and Blenis, 2012). Whether nuclear translocation precedes or follows RS6K phosphorylation by PDPK1 is unclear.
R-HSA-975311 (Reactome) The 5-hydroxytryptamine receptor (HTR3) family are members of the superfamily of ligand-gated ion channels (LGICs). Five receptors (HTR3A-E) can form a homopentamer (HTR3A) or heteropentamers (HTR3A with B, C, D or E) (Barrera et al. 2005, Niesler et al. 2007; reviews - Barnes et al. 2009, Wu et al. 2015) Although heterpentamer composition can vary between the two receptors binding, the example 2xHTR3A:3xHTR3(B-E) is shown here. Binding of the neurotransmitter 5-hydroxytryptamine (5HT, serotonin) to the HTR3 complex opens the channel, which in turn, leads to an excitatory response in neurons and is permeable to sodium, potassium, and calcium ions (Miyake et al. 1995, Davies et al. 1999).
R-HSA-975340 (Reactome) The GABA(A) receptor (GABR) family belongs to the ligand-gated ion channel superfamily (LGIC). Its endogenous ligand is gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. There are six alpha subunits (GABRA) (Garrett et al. 1988, Schofield et al. 1989, Hadingham et al. 1993, Edenberg et al. 2004, Hadingham et al. 1993, Yang et al. 1995, Wingrove et al. 1992, Hadingham et al. 1996), three beta subunits (GABRB) (Schofield et al. 1989, Hadingham et al. 1993, Wagstaff et al. 1991), 2 gamma subunits (GABRG) (Khan et al. 1993, Hadingham et al. 1995) and a theta subunit (Bonnert et al. 1999) characterised to date. GABA(A) functions as a heteropentamer, the most common structure being 2 alpha subunits, 2 beta subunits and a gamma subunit (2GABRA:2GABRB:GABRG). An alternative heteropentamer with much less affinity for GABA is 2GABRA:GABRB:GABRG:GABRQ (Bonnert et al. 1999). Upon binding of GABA, both GABR complexes conduct chloride ions through their pore, resulting in hyperpolarisation of the neuron. This causes an inhibitory effect on neurotransmission by reducing the chances of a successful action potential occurring.
R-HSA-975389 (Reactome) The glycine receptor (GLR) is a ligand-gated ion channel. It is functional as a heteropentamer, consisting of alpha (GLRA) and beta (GLRB) subunits. With no ligand bound, the receptor complex is closed to chloride ions. Binding of the inhibitory neurotransmitter glycine (Gly) to this receptor complex increases chloride conductance into neurons and thus produces hyperpolarization (inhibition of neuronal firing) (Grenningloh et al. 1990, Nikolic et al. 1998, Handford et al. 1996).
R-HSA-975449 (Reactome) The GABA(A)-rho receptor (GABRR) is expressed in many areas of the brain, but in contrast to other GABA(A) receptors, has especially high expression in the retina. It is functional as a homopentamer and is permeable to chloride ions when GABA binds to it (Cutting et al. 1991, Cutting et al. 1992, Bailey et al. 1990).
RasGRF:Ca/calmodulinArrowR-HSA-442760 (Reactome)
RasGRF:Ca/calmodulinmim-catalysisR-HSA-442732 (Reactome)
RasGRFR-HSA-442760 (Reactome)
RasGTP-B raf compexR-HSA-442726 (Reactome)
Ribosomal S6 kinaseR-HSA-444253 (Reactome)
TARP-PSD95-Mdm2ArrowR-HSA-416320 (Reactome)
TARP-PSD95-Mdm2R-HSA-416320 (Reactome)
TSPAN7:PICK1TBarR-HSA-416985 (Reactome)
cAMPArrowR-HSA-442715 (Reactome)
p-CAMKK1ArrowR-HSA-442749 (Reactome)
p-S133-CREB1ArrowR-HSA-442724 (Reactome)
p-S133-CREB1ArrowR-HSA-443474 (Reactome)
p-S133-CREB1ArrowR-HSA-443475 (Reactome)
p-S133-CREB1ArrowR-HSA-443480 (Reactome)
p-S338-RAF1mim-catalysisR-HSA-442737 (Reactome)
p-T185,Y187-MAPK1ArrowR-HSA-442737 (Reactome)
p-T185,Y187-MAPK1mim-catalysisR-HSA-444253 (Reactome)
phospho-CaMK IV:CalmodulinArrowR-HSA-111915 (Reactome)
Personal tools